Current Strategies in the Management of Irritable Bowel Syndrome

Abstract

Irritable bowel syndrome (IBS) is one of the most studied and discussed problems in the field of gastroenterology, yet it often remains perplexing to both clinicians and patients. Some of the apprehension comes from a void of objective data that defines a diagnosis in most disorders. This level of comfort is not appreciated in the evaluation of IBS, where the art of medicine and subjective impressions are the cornerstones of proper assessment. Though this paper focuses on management, a review of pathophysiology and specific guidelines establishing a diagnosis of IBS will be addressed.

Effectiveness of Anise Oil for Treatment of Mild to Moderate Depression in Patients With Irritable Bowel Syndrome

“…For those patients aged 50 years and older, it was mandatory to have had a colonoscopy within the previous 5 years. 15 Exclusion criteria comprised sever form of depression, pregnancy or breast milking mothers, abnormal baseline laboratory tests, history of previous abdominal surgery, confirmed organic disorders of the large or small bowel, any negative symptoms in favor of gastrointestinal malignancies like rectal bleeding, 16 diagnosis of any medical condition associated with constipation (other than IBS) or mechanical obstruction, any form of diagnosed cancer, and abuse of alcohol or any types of narcotic or antidepressant drugs. 14…”